CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11,314 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02957357
NCT02957357N/ACompleted

Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors

Alliance Foundation Trials, LLC.·observational·Posted Nov 7, 2016·Updated Oct 20, 2021

In Brief

An observational study for Cancer of Prostate and 3 related conditions. Completed, enrolled 11,314 participants.

Detailed Summary

Through this study, the investigators seek to identify the benefits (improved survival) and harms (more procedures, more treatment, side effects, and quality-of-life impact) from different surveillance frequencies-every three vs. six vs. 12 months. Using the National Cancer Database and quality-of-life data from a large group of prostate cancer survivors, the investigators aim to compare survival, procedures/tests, treatments, and side effects in prostate cancer survivors who are followed with alternative surveillance frequencies and compare quality-of-life outcomes. The overall goal of the study is to provide high-quality data that will allow development of a personalized, risk-based tailored approach to post-treatment surveillance for prostate cancer.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 7, 2016
Enrollment StartFeb 1, 2016
Primary CompletionJan 31, 2019
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 9.7 years ago